vs
Side-by-side financial comparison of ARGENX SE (ARGX) and Brightstar Lottery PLC (BRSL). Click either name above to swap in a different company.
Brightstar Lottery PLC is the larger business by last-quarter revenue ($2.5B vs $2.5B, roughly 1.0× ARGENX SE). ARGENX SE runs the higher net margin — 35.5% vs 5.9%, a 29.6% gap on every dollar of revenue. ARGENX SE produced more free cash flow last quarter ($322.4M vs $-415.0M).
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.
ARGX vs BRSL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.5B | $2.5B |
| Net Profit | $877.2M | $147.0M |
| Gross Margin | 89.5% | — |
| Operating Margin | 28.9% | 11.9% |
| Net Margin | 35.5% | 5.9% |
| Revenue YoY | 83.2% | — |
| Net Profit YoY | 1.3% | — |
| EPS (diluted) | $13.25 | $0.74 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.5B | $2.5B | ||
| Q2 25 | $1.8B | — | ||
| Q4 24 | $1.4B | — | ||
| Q2 24 | $901.9M | — | ||
| Q4 23 | — | $2.5B | ||
| Q2 23 | $510.9M | — | ||
| Q4 22 | — | $2.6B |
| Q4 25 | $877.2M | $147.0M | ||
| Q2 25 | $414.8M | — | ||
| Q4 24 | $865.6M | — | ||
| Q2 24 | $-32.5M | — | ||
| Q4 23 | — | $156.0M | ||
| Q2 23 | $-123.2M | — | ||
| Q4 22 | — | $275.0M |
| Q4 25 | 89.5% | — | ||
| Q2 25 | 89.2% | — | ||
| Q4 24 | 90.2% | — | ||
| Q2 24 | 89.4% | — | ||
| Q4 23 | — | — | ||
| Q2 23 | 91.7% | — | ||
| Q4 22 | — | — |
| Q4 25 | 28.9% | 11.9% | ||
| Q2 25 | 19.2% | — | ||
| Q4 24 | 8.7% | — | ||
| Q2 24 | -15.4% | — | ||
| Q4 23 | — | 29.7% | ||
| Q2 23 | -40.3% | — | ||
| Q4 22 | — | 28.6% |
| Q4 25 | 35.5% | 5.9% | ||
| Q2 25 | 23.4% | — | ||
| Q4 24 | 64.1% | — | ||
| Q2 24 | -3.6% | — | ||
| Q4 23 | — | 6.2% | ||
| Q2 23 | -24.1% | — | ||
| Q4 22 | — | 10.6% |
| Q4 25 | $13.25 | $0.74 | ||
| Q2 25 | $6.32 | — | ||
| Q4 24 | $13.33 | — | ||
| Q2 24 | $-0.55 | — | ||
| Q4 23 | — | $0.77 | ||
| Q2 23 | $-2.21 | — | ||
| Q4 22 | — | $1.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.5B | $1.4B |
| Total DebtLower is stronger | — | $4.1B |
| Stockholders' EquityBook value | $7.3B | $875.0M |
| Total Assets | $8.7B | $9.2B |
| Debt / EquityLower = less leverage | — | 4.64× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.5B | $1.4B | ||
| Q2 25 | $2.1B | — | ||
| Q4 24 | $1.5B | — | ||
| Q2 24 | $1.4B | — | ||
| Q4 23 | — | $508.0M | ||
| Q2 23 | $1.1B | — | ||
| Q4 22 | — | $590.0M |
| Q4 25 | — | $4.1B | ||
| Q2 25 | — | — | ||
| Q4 24 | — | — | ||
| Q2 24 | $11.0M | — | ||
| Q4 23 | — | $5.7B | ||
| Q2 23 | — | — | ||
| Q4 22 | — | $5.7B |
| Q4 25 | $7.3B | $875.0M | ||
| Q2 25 | $6.1B | — | ||
| Q4 24 | $5.5B | — | ||
| Q2 24 | $4.3B | — | ||
| Q4 23 | — | $1.4B | ||
| Q2 23 | $2.9B | — | ||
| Q4 22 | — | $1.4B |
| Q4 25 | $8.7B | $9.2B | ||
| Q2 25 | $7.2B | — | ||
| Q4 24 | $6.2B | — | ||
| Q2 24 | $4.8B | — | ||
| Q4 23 | — | $10.5B | ||
| Q2 23 | $3.2B | — | ||
| Q4 22 | — | $10.4B |
| Q4 25 | — | 4.64× | ||
| Q2 25 | — | — | ||
| Q4 24 | — | — | ||
| Q2 24 | 0.00× | — | ||
| Q4 23 | — | 3.92× | ||
| Q2 23 | — | — | ||
| Q4 22 | — | 3.98× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $323.3M | $-99.0M |
| Free Cash FlowOCF − Capex | $322.4M | $-415.0M |
| FCF MarginFCF / Revenue | 13.0% | -16.5% |
| Capex IntensityCapex / Revenue | 0.0% | 12.6% |
| Cash ConversionOCF / Net Profit | 0.37× | -0.67× |
| TTM Free Cash FlowTrailing 4 quarters | $594.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $323.3M | $-99.0M | ||
| Q2 25 | $361.8M | — | ||
| Q4 24 | $41.9M | — | ||
| Q2 24 | $-124.7M | — | ||
| Q4 23 | — | $1.0B | ||
| Q2 23 | $-285.4M | — | ||
| Q4 22 | — | $899.0M |
| Q4 25 | $322.4M | $-415.0M | ||
| Q2 25 | $356.6M | — | ||
| Q4 24 | $40.9M | — | ||
| Q2 24 | $-125.5M | — | ||
| Q4 23 | — | $865.0M | ||
| Q2 23 | $-285.9M | — | ||
| Q4 22 | — | $737.0M |
| Q4 25 | 13.0% | -16.5% | ||
| Q2 25 | 20.1% | — | ||
| Q4 24 | 3.0% | — | ||
| Q2 24 | -13.9% | — | ||
| Q4 23 | — | 34.2% | ||
| Q2 23 | -56.0% | — | ||
| Q4 22 | — | 28.4% |
| Q4 25 | 0.0% | 12.6% | ||
| Q2 25 | 0.3% | — | ||
| Q4 24 | 0.1% | — | ||
| Q2 24 | 0.1% | — | ||
| Q4 23 | — | 5.8% | ||
| Q2 23 | 0.1% | — | ||
| Q4 22 | — | 6.2% |
| Q4 25 | 0.37× | -0.67× | ||
| Q2 25 | 0.87× | — | ||
| Q4 24 | 0.05× | — | ||
| Q2 24 | — | — | ||
| Q4 23 | — | 6.49× | ||
| Q2 23 | — | — | ||
| Q4 22 | — | 3.27× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
